Proniras Corporation is a specialty pharmaceutical company based in Seattle, WA, dedicated to developing innovative therapies for individuals battling addiction and seizure disorders.
With a strong focus on research and development, Proniras Corporation has secured significant grants and contracts, including a prestigious award from the National Institute on Drug Abuse, to pursue effective treatments for opioid withdrawal and nerve agent-induced seizures.
Generated from the website